Introduction: Multiprofessional support for families that have a child with DM1 seems to be essential, since this chronic condition directly interferes with the family's daily life and requires treatment that requires constant monitoring throughout life. Objectives: To analyze the importance of multidisciplinary and, above all, family support in children with DM1. Methodology: This is an integrative literature review, prepared and conducted using the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) flowchart. The chosen databases were SciELO, LILACS and PubMed and the following descriptors were defined: “diabetes mellitus tipo 1”, “crianças” and “equipe multiprofissional” and their variations and combinations in English. Results and discussion: After the search, 9 articles were selected. According to the results, the multidisciplinary team acts in 3 ways in the care of children and adolescents with DM1: building long-term relationships, integrating knowledge through multidisciplinary teamwork and ensuring adequate documentation. Different professional groups must work as a team in order to provide optimal conditions for high-quality care for these patients. As for family support, it is essential for greater patient autonomy during treatment. Conclusions: The good relationship between the patient's family and the strong performance of a multidisciplinary team present are factors that directly and positively impact the results of the child's exams and their well-being.
Em 11 de fevereiro de 2020 a Organização Mundial de Saúde (OMS) denominou uma nova doença, Coronavírus 19 (COVID-19) e sendo declarada a pandemia em março de 2021. A COVID-19 é causada por Coronavírus 2 de Síndrome Respiratória Aguda Grave (SARS- CoV-2). Gestantes foram suscetíveis a desenvolver um quadro clínico mais grave. A COVID-19 se relaciona a desfechos maternos e fetais adversos, incluindo admissão na Unidade de Terapia Intensiva (UTI), cesariana, sofrimento fetal e parto prematuro. Esta revisão integrativa teve como objetivo identificar os fatores que contribuem para que gestantes com COVID-19 evoluam para parto prematuro. Foram seguidos os critérios propostos pelo Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA), a partir de publicações cientificas encontradas nas bases de dados Science Direct, PubMed e Biblioteca Virtual em Saúde (BVS/MEDLINE), direcionada com o auxílio dos descritores “preterm birth”, “premature birth labor”, “pregnancy” e “coronavirus infection”, verificados no Descritores em Ciências da Saúde. Foram eleitos os seguintes critérios de inclusão: responder à pergunta principal, artigos publicados entre os anos de 2019 e 2021 e nos idiomas inglês e português. Como resultados o estudo contou com uma amostra de 10 artigos que preencheram os critérios de inclusão, sendo que os estudos deveriam apresentar fatores de risco que influenciassem a progressão do parto prematuro em gestantes infectadas por COVID-19. Conclui-se, portanto, que um conjunto de fatores podem desencadear o parto prematuro, como a infecção por SARS-CoV-2 no terceiro trimestre da gestação, comorbidades, a coinfecção bacteriana, hipoxemia placentária, coagulopatias, transtornos mentais e iatrogênia. No entanto, é necessário estudos com uma população maior para homogeneizar os resultados.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.